2011
DOI: 10.1002/hed.21983
|View full text |Cite
|
Sign up to set email alerts
|

Phase I study of weekly docetaxel and cisplatin arterial infusion for recurrent head and neck cancer

Abstract: The recommended dose for weekly arterial infusion of docetaxel was identified as 12 mg/m(2) combined with weekly cisplatin at 40 mg/m(2) , with 4 courses of each.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 49 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?